ResMed | RMD - Market Capitalization

Stock Price
251.41
Daily Change
-3.33 -1.31%
Monthly
2.47%
Yearly
4.55%
Q1 Forecast
250.35

ResMed reported $37.63B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Ansell USD 2.91B 2.03B Jun/2025
AtriCure USD 1.75B 130M Sep/2025
Baxter International USD 11.7B 3.84B Sep/2025
Cochlear AUD 19.65B 679.76M Jun/2025
Cooper Companies USD 13.9B 205M Sep/2025
CSL USD 76.3B 60.04B Jun/2025
Dexcom USD 26.39B 7.84B Sep/2025
Edwards Lifesciences USD 45.66B 219M Sep/2025
Fisher Paykel Healthcare NZD 22.81B 1.05B Feb/2026
Globus Medical USD 7.74B 255M Sep/2025
Haemonetics USD 2.32B 1.22B Sep/2025
Hologic USD 16.62B 1.67B Dec/2025
Idexx Laboratories USD 53.12B 901M Feb/2026
Insulet USD 21.73B 374M Sep/2025
Integra LifeSciences USD 1.12B 163M Sep/2025
Intuitive Surgical USD 200.77B 40.45B Dec/2025
Masimo USD 7.68B 1.44B Sep/2025
Medtronic USD 120.14B 1.06B Sep/2025
Philips EUR 22.19B 2.53B Sep/2025
ResMed USD 35.16B 4.79B Dec/2025
Sigma Healthcare AUD 3.05B 1.63B Jan/2026
Sonic Healthcare AUD 12.87B 105.69M Jun/2025
Steris USD 24.37B 740M Sep/2025
Teleflex USD 5.3B 73M Sep/2025
Thermo Fisher Scientific USD 217.7B 42.4B Dec/2025